Skip to content

Change in Airway Responsiveness After Allergen Exposure

Allergen Induced Increase in Indirect Non-allergic Bronchial Reactivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01699594
Enrollment
11
Registered
2012-10-03
Start date
2012-10-31
Completion date
2014-05-31
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Asthma

Keywords

asthma, allergies, mannitol, methacholine

Brief summary

Exposure to allergens changes the way the airway responds to some stimuli (methacholine). The investigators will look at whether or not exposure to allergens changes the way the airway responds to a different stimuli (mannitol) and compare that with the known stimuli (methacholine).

Interventions

DRUGMannitol

Indirect bronchoprovocation agent being compared to direct bronchoprovocation agent (methacholine)

Direct bronchoprovocation agent being compared to indirect bronchoprovocation agent (mannitol)

Sponsors

University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* mild, allergic asthma * FEV1 greater than 70% predicted * methacholine PC20 less than or equal to 16mg/ml

Exclusion criteria

* known sensitivity to mannitol or other excipient * diagnosis of any other respiratory or non respiratory disease/disorder that would preclude the individual from participating * recent thoracic, abdominal or eye surgery * recent allergen exposure (4 weeks), respiratory infection (6 weeks) * current immunotherapy * pregnancy * history of anaphylaxis * use of asthma therapies other than short acting beta agonist

Design outcomes

Primary

MeasureTime frame
Change from baseline in airway responsiveness three hours after allergen exposureChange from Baseline at 3 hours

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026